Medicines Patent Pool deal to make cancer drug cheaper

Move could make Nilotinib, the drug used in the treatment of chronic myeloid leukaemia, more affordable; the firms can now manufacture generic versions of the drug in India and seven other middle-income countries and supply it in 44 territories

from | The Hindu